Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-21-003295

Chief Financial Officer sold 13,038 shares at an average $81.02 ($1,056,310)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Myszkowski Kenneth Allen Chief Financial Officer 2021-01-11 Sale −11,597 $81.02 $939,589 445,446 D
Myszkowski Kenneth Allen Chief Financial Officer 2021-01-12 Sale −1,441 $81.00 $116,721 444,005 D
Open-market sales · 13,038 sh · avg $81.02 · $1,056,310
Loading xslF345X03/doc4.xml…